Forsvar

​De seneste års forsvar på SDCC.

2021
Ph.d. - afhandlinger

Regitze Saurbrey Pals: Like walking a tightrope: Meanings and practices of care and support among pre-teens with type 1-diabetes and their families.
6. september 2021

Lea Bruhn:The effects of exercise, dapagliflozin or metformin on markers of glucometabolic function in individuals at high risk of developing type 2 diabetes.
8. oktober 2021

2020

Ph.d. - afhandlinger

Nicklas Järvelä Johansen. Treatment with short-acting GLP-1 receptor agonism in type 1 diabetes: the MAG1C trial. 
18. august 2020

Maria Overvad. Diabetes complications in Greenland: CVD and diabetic kidney disease in a unique genetic population.
28.august 2020.

Alexander Christensen. Incretin-based therapy as add-on to sulfonylurea in patients with hepatocyte nuclear factor 1-alpha diabetes.
7. september.2020.

Helle Nergaard Grønbæk: When motivation is not enough - Psychological aspects of family treatment of childhood obesity
9. oktober 2020.

Jessica Bengtsson: Childhood adversities and type 1 diabetes risk
30. oktober 2020

Isabelle Isa Kristin Steineck: Insulin pump and continuous glucose monitoring in type 1 diabetes. 
13. november 2020.

Signe Abitz Winther: Gut microbiota and derived metabolites in micro- and macro vascular complications of diabetes.
30. november 2020.

2019

Ph.d. - afhandlinger

Lasse Bjerg. Clustering of microvascular complications in type 1 diabetes. 
16. januar 2019

Hanin Amidid. Which physical activity patternes prevent diabetes and cardiovascular disease in people with elevated diabetes risk?
21. juni 2019

2018

Disputats

Bernt Johan von Scholten. Cardiovascular risk stratification and renal effects of weight loss and GLP-1 receptor agonism in type 2 diabetes.
Københavns Universitet.
14. maj 2018

 

Ph.d.- afhandlinger

Pernille Falberg Rønn. Obesity-associated cardiometabolic risk: the influence of ethnicity.
5. januar 2018

Jens Øllgaard. Long-term Metabolic Memory for Micro-and Macrovascular Complications in Type 2-diabetes. STENO-2: monitoring of well-defined endpoints 12 years after end of 7.8 years of intensive, multifactorial treatment.
2. februar 2018

Narges Safai. Personalized treatment of type 2 diabetes using clinical and metabolomics data.
Københavns Universitet.
27. februar 2018

Tina Jorsal. An enteroendocrine perspective on type 2 diabetes and obesity
8. marts 2018

Sascha Pilemann-Lyberg. Uric Acid and its role in diabetic nephropathy and cardiovascular disease in patients with type 1 diabetes.
5. april 2018

Ulla Møller Hansen. Between a rock and a hard place. The psychosocial burden of type 1 diabetes in work life: Conceptualization, measurement, and consequences.
14. maj 2018

Natasja Kingod. THE TINKERING M-PATIENT:An (Auto-)Praxiographic Study of Attuning to a Life with Type 1 Diabetes through Online and Offline Support.
16. maj 2018

Vibeke Stenov.  Person-centered methods in group-based diabetes education - An intervention study investigating, developing, and implementing new approaches.
4. juni 2018.

Lene Munch.Risk stratification of a population with type 2 diabetes and shared care management of patients with intermediate risk across the primary and secondary health care sectors.
28. september 2018


Redaktør